the importance of quality metrics in kidney cancer care
Published 5 years ago • 54 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
5:11
current treatment landscape for kidney cancer
-
1:59
key objectives in kidney cancer: treatment sequencing & refining clinical endpoints
-
0:29
hope for the future of kidney cancer treatment
-
4:15
the unmet needs of kidney cancer treatment
-
0:35
potential of immunotherapy for kidney cancer
-
0:55
the emerging continuum of care in metastatic kidney cancer in the second-line and beyond
-
1:18
using radiotherapy to manage oligometastatic kidney cancer
-
2:16
the agents at the forefront of kidney cancer treatment
-
0:58
how can we improve outcomes for patients with kidney cancer who receive immunotherapy?
-
6:34
kidney cancer – an introduction
-
1:11
impact of the tme on car t-cell therapy for kidney cancer
-
1:12
papillary kidney cancer: prognosis & therapy efficacy
-
0:48
will immunotherapy take over the treatment landscape of patients high-risk renal cell carcinoma?
-
30:21
kidney cancer breakout: new treatments to preserve quality of life
-
35:46
kidney cancer: keeping the best quality of life with kidney cancer
-
1:15
changing kidney cancer treatment landscape
-
1:02
an expert looks to the future of metastatic kidney cancer treatment
-
5:18
are combination therapies the future of renal cell carcinoma treatment?
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial